Most Popular Brands: Rebif
Interferon beta-1a is an immunomodulator used to prevent episodes of symptoms and slow the development of disability in patients with relapsing-remitting multiple sclerosis. It comes as a solution to inject subcutaneously (under the skin) three times a week, ideally the same 3 days each week.
| Reasons taken | # of patients | Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Slow my MS progress | 1274 |
|
|
|
|
|
214 |
| Multiple Sclerosis (MS) | 75 |
|
|
|
|
|
31 |
| Other | 47 |
|
|
|
6 | ||
| Stiffness/Spasticity | 17 |
|
|
|
4 | ||
| General health | 15 |
|
|
|
|
|
7 |
| Fatigue | 14 |
|
1 |
See all 1140 patients currently taking Interferon beta-1a SubQ injection
Mouse over the table for more information
Top 10 dosages based on patients currently taking Interferon beta-1a SubQ injection. See all 142 dosages ►
| 0.44 mg as needed | 132mcg weekly | 22 mcg/0.5 mL as needed | 22mcg/0.5mL as needed | 3 44mcg/0.5mL as needed | 3 times a week | 44 mcg/0.5 mL all the time (24/7) | 44 mcg/0.5 mL as needed | 44mcg/0.5mL as needed | 44 mcg all the time (24/7) | 44mcg as needed | 44 mg all the time (24/7) | 44mg as needed | - as needed | as needed | daily | monthly | weekly | 0.14 mcg | 0.44 mg weekly | 0.5 mcg weekly | 0.5 mg weekly | 0.22 mg | 0.25 mcg | 0.25 mg | 1 g weekly | 1 weekly | 0.3 mcg | 0.3 mg | 1.1 weekly | 0.44 mcg | 0.5 mcg | 0.44 | 0.44 mcg | 0.44 mg | 0.5 mcg | 0.3 mcg daily | 0.3 mg daily | 0.8 mcg | 0.75 mg | 1 mcg | 3 mcg weekly | 3 mg weekly | 3 weekly | 1 | 1 mcg | 1 mg | 4.4 mcg weekly | 30 mcg/0.5 mL monthly | 1 mL daily | 8.8 mcg weekly | 3 mcg | 3 mcg | 3 mg | 4.4 mcg | 15 mcg weekly | 20 mg weekly | 3 mg daily | 22 mcg/0.5 mL weekly | 22 mcg weekly | 22 mg weekly | 26.4 mcg weekly | 10 mcg | 30 mcg/0.5 mL weekly | 30 mcg weekly | 30 mg weekly | 8.8 mg | 33 mg weekly | 10 | 12 mcg | 40 mcg weekly | 40.5 mcg weekly | 44 mcg/0.5 mL weekly | 44 mcg weekly | 44 mg weekly | 44 weekly | 60 mg weekly | 8.8 mcg daily | 8.8 mg daily | 22 mcg | 22 mcg/0.5 mL | 22 mcg/0.5 mL 3 times a week | 3 x 22 mcg/0.5 mL weekly | 66 mcg weekly | 66 mg weekly | 10 mg daily | 22 | 22 mcg | 22 mg | 25 mg | 2 x 44 mcg/0.5 mL weekly | 88 mcg weekly | 30 mcg/0.5 mL 3 times a week | 33 mcg | 99 mcg weekly | 30 mcg | 112 mcg weekly | 40 mcg | 120 mg weekly | 12 x 44 mcg/0.5 mL monthly | 126 mcg weekly | 44 mcg | 44 mcg/0.5 mL 3 times a week | 132 mcg weekly | 132 mg weekly | 3 x 44 mcg/0.5 mL weekly | 40 | 41 mcg | 43 mg | 152 mg weekly | 22 mcg/0.5 mL daily | 22 mcg daily | 44 | 44 g | 44 mcg | 44 mg | 4 x 44 mcg/0.5 mL weekly | 30 mcg/0.5 mL daily | 30 mcg daily | 6 x 44 mcg/0.5 mL weekly | 100 mcg | 300 weekly | 44 mcg/0.5 mL daily | 44 mcg/0.5 mL one time | 44 mcg daily | 132 mcg | 138 mcg | 125 | 132 mcg | 144 mg | 100 mcg daily | 200 mcg | 200 mg | 132 mcg daily | 3 x 44 mcg/0.5 mL daily | 321 mcg | 300 mg | 200 g daily | 250 mcg daily | 500 mcg | 300 other daily | 44 mcg | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1
|
1
|
1
|
3
|
1
|
30
|
1
|
4
|
11
|
1
|
3
|
1
|
1
|
1
|
4
|
15
|
1
|
24
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
1
|
2
|
2
|
8
|
1
|
2
|
1
|
2
|
1
|
3
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
3
|
2
|
2
|
3
|
2
|
1
|
1
|
1
|
2
|
1
|
1
|
2
|
1
|
1
|
1
|
1
|
7
|
3
|
3
|
1
|
1
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
63
|
35
|
16
|
1
|
1
|
1
|
1
|
8
|
1
|
15
|
30
|
4
|
2
|
1
|
2
|
2
|
5
|
1
|
1
|
1
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
3
|
1
|
87
|
55
|
34
|
17
|
184
|
1
|
1
|
1
|
1
|
13
|
2
|
19
|
1
|
36
|
77
|
1
|
2
|
6
|
1
|
1
|
1
|
86
|
1
|
17
|
1
|
1
|
1
|
1
|
1
|
1
|
3
|
1
|
1
|
3
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
||
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
|
Side effects too severe
|
274 | 49% |
|
|
Did not seem to work
|
176 | 32% |
|
|
Doctor's advice
|
129 | 23% |
|
|
Other
|
91 | 16% |
|
|
Personal research
|
26 | 5% |
|
|
Expense
|
21 | 4% |
|
|
Not indicated
|
14 | 3% |
|
|
Course of treatment ended
|
10 | 2% |
|
See all 541 patients who’ve stopped taking Interferon beta-1a SubQ injection
See more information, including instructions, precautions, side effects, and interactions.
Report created on November 20, 2009.